A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma

S Lonial,Dixil Francis,Chatchada Karanes,Suzanne Trudel,Akari M. Dollard,Donald Harvey,Jonathan L. Kaufman

A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma

2009

S Lonial
Dixil Francis
Chatchada Karanes
Suzanne Trudel
Akari M. Dollard
Donald Harvey
Jonathan L. Kaufman

8597 Background: Preclinical work from our group has demonstrated that the combination of a farnesyl transferase inhibitor and bortezomib results in enhanced plasma cell apoptosis, and more recentl...

Keywords:

Clinical trial
Refractory Multiple Myeloma
Oncology
Bortezomib
Tipifarnib
Medicine
Internal medicine
Farnesyl Transferase Inhibitor
Apoptosis
Multiple myeloma
Pathology
relapsed refractory
Plasma cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations